Design and Implementation Issues of an Information System Supporting Cervical Cancer Screening Programs
暂无分享,去创建一个
Dimitra Iliopoulou | Abraham Pouliakis | Effrosyni Karakitsou | D. Iliopoulou | A. Pouliakis | Effrosyni Karakitsou
[1] G. Koliopoulos,et al. High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study. , 2011, Gynecologic oncology.
[2] J. Val-Bernal,et al. A type‐specific study of human papillomavirus prevalence in cervicovaginal samples in three different Spanish regions , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[3] A. Jemal,et al. Global Cancer Statistics , 2011 .
[4] Thomas Wetter,et al. Artificial neural network may perform good to predict the survivability of cervical cancer , 2006, AMIA.
[5] C. Poole,et al. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. , 2008, American journal of epidemiology.
[6] A. Spathis,et al. Identification of Women for Referral to Colposcopy by Neural Networks: A Preliminary Study Based on LBC and Molecular Biomarkers , 2012, Journal of biomedicine & biotechnology.
[7] E. Franco,et al. Persistent human papillomavirus infection and cervical neoplasia. , 2002, The Lancet. Oncology.
[8] D. Grobbee,et al. Less medical intervention after sharp demarcation of Grade 1‐2 cervical intraepithelial neoplasia smears by neural network screening , 2001, Cancer.
[9] Maria Rosaria Giovagnoli,et al. Cervical False Negative Cases Detected by Neural Network–Based Technology , 2002, Acta Cytologica.
[10] G. Koliopoulos,et al. Clinical management of HPV‐related disease of the lower genital tract , 2010, Annals of the New York Academy of Sciences.
[11] S. Franceschi,et al. Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update , 2007, International journal of cancer.
[12] M. Kyrgiou,et al. The Evaluation of p16ink4a Immunoexpression/Immunostaining and Human Papillomavirus DNA Test in Cervical Liquid-Based Cytological Samples , 2010, International Journal of Gynecologic Cancer.
[13] B. Patterson,et al. High-throughput cervical cancer screening using intracellular human papillomavirus E6 and E7 mRNA quantification by flow cytometry. , 2005, American journal of clinical pathology.
[14] T. Kelesidis,et al. Human papillomavirus (HPV) detection using in situ hybridization in histologic samples: correlations with cytologic changes and polymerase chain reaction HPV detection. , 2011, American journal of clinical pathology.
[15] J. Smith. Bethesda 2001 , 2002, Cytopathology : official journal of the British Society for Clinical Cytology.
[16] K. Syrjänen,et al. Cervical cancer screening in Mediterranean countries: implications for the future , 2010, Cytopathology : official journal of the British Society for Clinical Cytology.
[17] Petros Karakitsos,et al. A preliminary study of the potential of tree classifiers in triage of high-grade squamous intraepithelial lesions. , 2011, Analytical and quantitative cytology and histology.
[18] S. Adalsteinsson,et al. Trends in cervical and breast cancer in Iceland. A statistical evaluation of trends in incidence and mortality for the period 1955–1989, their relation to screening and prediction to the year 2000 , 1991, International journal of cancer.
[19] P. Martin-Hirsch,et al. Commentary: Have we dismissed ablative treatment too soon in colposcopy practice? , 2006, BJOG : an international journal of obstetrics and gynaecology.
[20] D. Solomon,et al. The Bethesda system for reporting cervical cytology : definitions, criteria, and explanatory notes , 2004 .
[21] P. Martin-Hirsch,et al. Alterations in human papillomavirus-related biomarkers after treatment of cervical intraepithelial neoplasia. , 2011, Gynecologic oncology.
[22] D. McCance. Human papillomavirus (HPV) infections in the aetiology of cervical cancer. , 1988, Cancer surveys.
[23] Fred Russell Kramer,et al. Multicolor molecular beacons for allele discrimination , 1998, Nature Biotechnology.
[24] N. Agnantis,et al. The natural history of HPV infection of the uterine cervix. Long-term observational and histological data. , 2002, Anticancer research.
[25] O. F. Kraushaar,et al. The Papanicolaou test in the cancer control program. , 1949, The Journal of the Kansas Medical Society.
[26] M. Boon,et al. Consequences of neural network technology for cervical screening: Increase in diagnostic consistency and positive scores , 1996, Cancer.
[27] A. Spathis,et al. Promoter Methylation of p16INK4A, hMLH1, and MGMT in Liquid-Based Cervical Cytology Samples Compared with Clinicopathological Findings and HPV Presence , 2011, Infectious diseases in obstetrics and gynecology.
[28] M. von Knebel Doeberitz,et al. p16INK4a Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial Neoplasia , 2002, The American journal of surgical pathology.
[29] A. Malik. The role of human papilloma virus (HPV) in the aetiology of cervical cancer. , 2005, JPMA. The Journal of the Pakistan Medical Association.
[30] G. Koliopoulos,et al. Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: predictors and clinical implications. , 2011, Gynecologic oncology.
[31] M. Kyrgiou,et al. The role of p16(INK4a) immunostaining in the risk assessment of women with LSIL cytology: a prospective pragmatic study. , 2011, European journal of gynaecological oncology.
[32] McCance Dj. Human papillomavirus (HPV) infections in the aetiology of cervical cancer. , 1988 .
[33] T. Rohan,et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. , 2001, JAMA.
[34] Pekka Nieminen,et al. Prospective and randomised public‐health trial on neural network‐assisted screening for cervical cancer in Finland: Results of the first year , 2003, International journal of cancer.
[35] A. Spathis,et al. Genetic Variability and Phylogeny of High Risk HPV Type 16, 18, 31, 33 and 45 L1 Gene in Greek Women , 2011, International journal of molecular sciences.
[36] J. Bourhis,et al. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA , 1990, The Lancet.
[37] A. Spathis,et al. Clinical performance of human papillomavirus E6, E7 mRNA flow cytometric assay compared to human papillomavirus DNA typing. , 2011, Analytical and quantitative cytology and histology.
[38] M. Henry. The Bethesda System 2001: an update of new terminology for gynecologic cytology. , 2003, Clinics in laboratory medicine.